BGC > Produktsuche > Dxd | 1599440-33-1

Description:
DXD, an Exatecan derivative for ADC, is a potent DNA topoisomerase I inhibitor with an IC50 of 0.31 μM. It can be used as a payload for antibody-conjugated drug ADCs targeting HER2.

• Molecular Weight:493.48
• Boiling Point:957.9±65.0°C (Predicted)
• Purity:≥95%

Molecular Formula:
C26H24FN3O6
Canonical SMILES:
CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)NC(=O)CO)O
InChI:
InChI=1S/C26H24FN3O6/c1-3-26(35)15-6-19-23-13(8-30(19)24(33)14(15)10-36-25(26)34)22-17(28-20(32)9-31)5-4-12-11(2)16(27)7-18(29-23)21(12)22/h6-7,17,31,35H,3-5,8-10H2,1-2H3,(H,28,32)/t17-,26-/m0/s1
InChIKey:
PLXLYXLUCNZSAA-QLXKLKPCSA-N
Solubility:
Soluble in DMSO
Appearance:
Solid Powder
Storage: Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years)
Synonyms:
N-((1S,9S)-9-Ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo(de)pyrano(3',4':6,7)indolizino(1,2-b)quinolin-1-yl)-2-hydroxyacetamide